CoChat

IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism

Open access
Pu, Jian, Wang, Jianchu, Qin, Zebang, Wang, Anmin, Zhang, Ya, Wu, Xianjian, Wu, Yi, Li, Wenchuan, Xu, Zuoming, Lu, Yuan, Tang, Qianli, Wei, Huamei · 2020 · Frontiers in Oncology
Cited by 156

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. N6‑methyladenosine (m6A) plays an important role in posttranscriptional gene regulation. METTL3 and IGF2BP2 are key genes in the m6A signal pathway and have recently been shown to play important roles in cancer development and progression. In our work, higher METTL3 and IGF2BP2 expression were found in HCC tissues and were associated with a poor prognosis. In addition, IGF2BP2 overexpression promoted HCC proliferation in vitro and in vivo. Mechanistically, IGF2BP2 directly recognized and bound to the m6A site on FEN1 mRNA and enhanced FEN1 mRNA stability. Overall, our study revealed that METTL3 and IGF2BP2, acting as an oncogene, maintained FEN1 expression through an m6A-IGF2BP2-dependent mechanism in HCC cells, and indicated a potential biomarker panel for prognostic prediction in liver Cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fonc.2020.578816

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 29

  1. International, 2018, Retracted: Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies, BioMed Res Int, 2018, 10.1155/2018/4560161 · doi:10.1155/2018/4560161
  2. Syed, 2020, Ramucirumab: A Review in Hepatocellular Carcinoma, Drugs, 80, 10.1007/s40265-020-01263-6 · DOI
  3. Yang, 2018, Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism, Cell Res, 28, 10.1038/s41422-018-0040-8 · DOI · Paper page
  4. Zlotorynski, 2015, RNA metabolism: m6A modulates RNA structure, Nat Rev Mol Cell Biol, 16, 10.1038/nrm3974 · doi:10.1038/nrm3974
  5. Taketo, 2017, The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells, Int J Oncol, 52, 10.3892/ijo.2017.4219 · DOI · Paper page
  6. Balacco, 2018, The m6A writer: Rise of a machine for growing tasks, Biochemistry, 58, 10.1021/acs.biochem.8b01166 · DOI · Paper page
  7. Deng, 2020, Clinical Significance of an m6A Reader Gene, IGF2BP2, in Head and Neck Squamous Cell Carcinoma, Front Mol Bioences, 7, 10.3389/fmolb.2020.00068 · DOI · Paper page
  8. Li, 2018, Author Correction: Suppression of m6A reader Ythdf2 promotes hematopoietic stem cell expansion, Cell Res, 28, 1042, 10.1038/s41422-018-0083-x · doi:10.1038/s41422-018-0083-x
  9. Dai, 2018, N6-methyladenosine links RNA metabolism to cancer progression, Cell Death Disease, 9, 124, 10.1038/s41419-017-0129-x · DOI · Paper page
  10. Wang, 2017, Roles of RNA methylation by means of N6-methyladenosine (m6A) in human cancers, Cancer Lett, 10.1016/j.canlet.2017.08.030 · DOI · Paper page
  11. Chao, 2019, Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China, Cancer Commun, 39, 42, 10.1186/s40880-019-0388-2 · DOI
  12. Hu, 2017, MARCH5 RNA promotes autophagy, migration, and invasion of ovarian cancer cells, Autophagy, 13, 10.1080/15548627.2016.1256520 · DOI
  13. Tong, 2018, Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells, Cancer Commun, 38, 56, 10.1186/s40880-018-0326-8 · DOI
  14. Cardenas, 2009, Induction of apoptosis in vitro and in vivo effects of a synthetic nitroflavone derivative on murine mammary adenocarcinoma cells, Cancer Res, 69, 2145, 10.1158/0008-5472.SABCS-2145 · doi:10.1158/0008-5472.sabcs-2145
  15. Tomczak, 2015, The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge, Contemp Oncol, 19, A68, 10.5114/wo.2014.47136 · DOI · Paper page
  16. Chen, 2018, RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2, Hepatol Off J Am Assoc Study Liver Dis, 67, 10.1002/hep.29683 · DOI · Paper page
  17. Du, 2012, Efficient typing of copy number variations in a segmental duplication-mediated rearrangement hotspot using multiplex competitive amplification, J Hum Genet, 57, 10.1038/jhg.2012.66 · DOI
  18. Xin, 2003, Molecular pathogenesis of human hepatocellular carcinoma, Toxicology, 10.1038/ng0802-339 · DOI · Paper page
  19. Mortezaee, 2018, Human hepatocellular carcinoma: Protection by melatonin, J Cell Physiol, 233, 10.1002/jcp.26586 · DOI · Paper page
  20. Qin, 2004, Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature, J Cancer Res Clin Oncol, 130, 497, 10.1007/s00432-004-0572-9 · DOI · Paper page
  21. Zhang, 2019, A Review in Research Progress Concerning m6A Methylation and Immunoregulation, Front Immunol, 10, 10.3389/fimmu.2019.00922 · DOI · Paper page
  22. Years, 2017, Rethinking m6A Readers, Writers, and Erasers, Annu Rev Cell Dev Biol, 33, 319, 10.1146/annurev-cellbio-100616-060758 · DOI · Paper page
  23. Zhou, 2019, Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA database, Aging, 10.18632/aging.101856 · DOI · Paper page
  24. Zhu, 2020, An oncopeptide regulates m6A recognition by the m6A reader IGF2BP1 and tumorigenesis, Nat Commun, 11, 1685, 10.1038/s41467-020-15403-9 · DOI · Paper page
  25. Liu, 2020, The emerging molecular mechanism of m6A modulators in tumorigenesis and cancer progression, Biomed Pharmacother, 127, 110098, 10.1016/j.biopha.2020.110098 · DOI
  26. Zaher, 2018, Missed cleavage opportunities by FEN1 lead to Okazaki fragment maturation via the long-flap pathway, Nucleic Acids Res, 6, 6, 10.1093/nar/gky082 · DOI
  27. He, 2017, FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer, Mol Oncol, 10.1002/1878-0261.12058 · DOI
  28. Chen, 2014, Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression, J Steroid Biochem Mol Biol, 143, 10.1016/j.jsbmb.2014.01.009 · DOI
  29. Li, 2011, Functional FEN1 genetic variants contribute to risk of hepatocellular carcinoma, esophageal cancer, gastric cancer and colorectal cancer, Carcinogenesis, 1, 1, 10.1093/carcin/bgr250 · DOI

Cited by

See all 156

Metadata

Authors
Pu, J., Wang, J., Qin, Z., Wang, A., Zhang, Y., Wu, X., Wu, Y., Li, W., Xu, Z., Lu, Y., Tang, Q., & Wei, H.
Venue
Frontiers in Oncology
Published
2020-11-02
Volume
10
Pages
578816-578816
ISSN
2234-943X (ISSN-L)
OpenAlex
W3096480398
Cited by
156
References
3
FWCI
6.15
Type
journal article
Language
en
Open access
gold
Funders
Scientific Research and Technology Development Program of Guangxi

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism. https://app.cochat.ai/papers/10.3389/fonc.2020.578816
The paper
Pu, J., Wang, J., Qin, Z., Wang, A., Zhang, Y., Wu, X., Wu, Y., Li, W., Xu, Z., Lu, Y., Tang, Q., & Wei, H. (2020). IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism. Frontiers in Oncology. https://doi.org/10.3389/fonc.2020.578816

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.